(i.e., less than formal psychomotor testing). While pharmacodynamic tolerance or adaptation to some adverse depressant effects of LUNESTA® may develop, patients using 3 mg LUNESTA® should be cautioned against driving or engaging in other hazardous activities or activities requiring complete ...
Rx only NDA 21-476 Approved Labeling Text Dated December 15, 2004 LUNESTA™ (eszopiclone) TABLETS 1 mg, 2 mg, 3 mg C-IV PRESCRIBING INFORMATION DESCRIPTION: LUNESTA (eszopiclone) is a nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The ...
In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2. Uses for Lunesta LUNESTA® (eszopiclone) is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance. ...
(i.e., less than formal psychomotor testing). While pharmacodynamic tolerance or adaptation to some adverse depressant effects of LUNESTA® may develop, patients using 3 mg LUNESTA® should be cautioned against driving or engaging in other hazardous activities or activities requiring complete ...